Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma

NCT03663725 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT03663725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03663725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Lead sponsor
Centre Oscar Lambret
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 13, 2019
Completion date
June 30, 2027
Enrollment
486 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma